From: Prohibitin: targeting peptide coupled to ovarian cancer, luteinization and TGF-β pathways
Parameters | Group | F (P) | |||
---|---|---|---|---|---|
Control | Benign | Borderline | Malignant | ||
LH (Mean ± SD) | 8.7 ± 1.6 | 18.8 d ± 4.4 | 4.5 ± 0.9 | 3.7 ± 1.4 | 0.001* |
TGF-B (Mean ± SD) | 1347.4 ± 594.2 | 1039.0 ± 686.4 | 994 ± 547.6 | 894.0 ± 547.6 | 0.065 |